Develops catheter-based systems that sense nerve signals and deliver targeted radiofrequency ablation, initially for clinicians treating pain associated with pancreatic cancer.
10-K for FY2026, filed May 27, 2026We are a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous…View ↗
Sensing Catheter: A proprietary microchip-enabled catheter that can detect, differentiate, and geolocate peripheral nerve signals in real…View ↗
We believe our technology has the potential to meaningfully advance the precision and clinical utility of treating peripheral nervous…View ↗
No revenue reported yet.
10-K for FY2026, filed May 27, 2026
Competes with Medtronic, Johnson & Johnson, Abbott, and Boston Scientific
10-K for FY2026, filed May 27, 2026We operate in highly competitive, innovation-driven markets: electrophysiology and interventional pain management, both dominated by large…View ↗
Loading...